Journal
CNS DRUGS
Volume 27, Issue 4, Pages 239-247Publisher
ADIS INT LTD
DOI: 10.1007/s40263-013-0042-5
Keywords
-
Categories
Ask authors/readers for more resources
There are currently nine approved disease modifying therapies for relapsing forms of multiple sclerosis, with six distinct mechanisms of action. All have side effects, and none are cures. When a patient cannot tolerate therapy, or there is unacceptable breakthrough disease activity, the most common approach is to change drug. No universal guidelines exist for switching therapy. This overview will propose switch principles and suggestions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available